- Home
- DMAA vs PACB Comparison
DMAA vs PACB Comparison
Compare DMAA & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMAA
- PACB
- Stock Information
- Founded
- DMAA 2024
- PACB 2000
- Country
- DMAA United States
- PACB United States
- Employees
- DMAA N/A
- PACB N/A
- Industry
- DMAA
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- DMAA
- PACB Industrials
- Exchange
- DMAA NYSE
- PACB Nasdaq
- Market Cap
- DMAA 341.5M
- PACB 364.2M
- IPO Year
- DMAA 2025
- PACB 2010
- Fundamental
- Price
- DMAA $10.21
- PACB $1.47
- Analyst Decision
- DMAA
- PACB Buy
- Analyst Count
- DMAA 0
- PACB 9
- Target Price
- DMAA N/A
- PACB $2.06
- AVG Volume (30 Days)
- DMAA 43.3K
- PACB 9.8M
- Earning Date
- DMAA 01-01-0001
- PACB 08-06-2025
- Dividend Yield
- DMAA N/A
- PACB N/A
- EPS Growth
- DMAA N/A
- PACB N/A
- EPS
- DMAA N/A
- PACB N/A
- Revenue
- DMAA N/A
- PACB $152,357,000.00
- Revenue This Year
- DMAA N/A
- PACB $3.33
- Revenue Next Year
- DMAA N/A
- PACB $18.52
- P/E Ratio
- DMAA N/A
- PACB N/A
- Revenue Growth
- DMAA N/A
- PACB N/A
- 52 Week Low
- DMAA $9.95
- PACB $0.85
- 52 Week High
- DMAA $10.27
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- DMAA N/A
- PACB 60.56
- Support Level
- DMAA N/A
- PACB $1.41
- Resistance Level
- DMAA N/A
- PACB $1.53
- Average True Range (ATR)
- DMAA 0.00
- PACB 0.10
- MACD
- DMAA 0.00
- PACB 0.01
- Stochastic Oscillator
- DMAA 0.00
- PACB 66.00
About DMAA DRUGS MADE IN AMER ACQUISITION CORP
Drugs Made In America Acquisition Corp is a blank check company.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.